Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Mirna_Therapeutics
|
| gptkbp:acquisitionYear |
2017
|
| gptkbp:focusesOn |
oncology therapeutics
nanoparticle-based drug delivery |
| gptkbp:foundedIn |
2003
|
| gptkbp:headquartersLocation |
gptkb:San_Antonio,_Texas,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Azaya Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
ATI-1123
|
| gptkbp:website |
http://www.azayatherapeutics.com
|
| gptkbp:bfsParent |
gptkb:David_Elmaleh
|
| gptkbp:bfsLayer |
7
|